Ohhira's Probiotics and Reg'Activ The Dynamic Duo
Farmaco 2003
The findings established Ipamorelin's defining characteristic: Growth hormone Ipamorelin produced dose-dependent GH release comparable to GHRP-6 Cortisol No significant cortisol elevation was observed with Ipamorelin, while GHRP-2 and GHRP-6 produced measurable cortisol increases Prolactin No significant prolactin elevation at GH-effective concentrations ACTH No significant ACTH stimulation, contrasting with the adrenocorticotropic effects of other GHRPs GHRP Selectivity Comparison (Preclinical Data) Compound GH Release Cortisol Effect Prolactin Effect ACTH Effect Ipamorelin Dose-dependent Minimal / none Minimal / none Minimal / none GHRP-2 Dose-dependent Moderate increase Moderate increase Moderate increase GHRP-6 Dose-dependent Moderate increase Moderate increase Moderate increase Hexarelin Strong Significant increase Significant increase Significant increase Data adapted from Raun et al
Sharma P, Ostermann L, Piya S, Baran N, Tyagi A, Hindley C, K-H D, Sims M, Battula L, Andreeff M , Borthakur G
Log in Description Our Glutathione Complex is now Cacao Raspberry flavor
This specific characteristic makes Ipamorelin a more targeted and potentially cleaner growth hormone releasing agent
